SciELO - Scientific Electronic Library Online

 
vol.16 número3Evaluación del Trofín en el tratamiento de la anemia ferripriva en niñosEstudio del reordenamiento molecular de los genes TEL/AML1 en la leucemia linfocítica aguda: Resultados preliminares índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Hematología, Inmunología y Hemoterapia

versión On-line ISSN 1561-2996

Resumen

SANCHEZ SEGURA, Miriam et al. Immunophenotyping in the diagnosis of lympho- and myeloproliferative syndromes  . Rev Cubana Hematol Inmunol Hemoter [online]. 2000, vol.16, n.3, pp. 198-205. ISSN 1561-2996.

The immunophenotyping of cells from bone marrow and from peripheral blood was carried out in 217 patients with lympho- and myeloproliferative syndromes by the immunocytochemical ultramicromethod (ICCUM). Of the total of studied cases, 143 (62.44%) were acute leukemias (AL): 70 acute lymphoid leukemias (ALL) and 38 acute myeloid leukemias (AML). There were not specific antigens of lineage in l5 patients, who were classified as undifferentiated acute leukemias. Among the ALL, 75.71% were of phenotype B, whereas the common one was the most frequent. In 17 patients (11.88%) the blasts expressed T-cell antigens. 66 patients (30.41%) presented chronic lymphoproliferative syndromes (CLPS) and, of them, 71.21% were of phenotype B. The frequency of acute and chronic lympho- and myeloproliferative syndromes found in our patients behaved according to what has been described by other authors

Palabras clave : BONE MARROW; DISORDERS, LYMPHOPROLIFERATIVE, DISORDERS; MYELOPROLIFERATIVE, DISORDERS; ANTIBODIES, MONOCLONAL.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License